Polar Pharma India Ltd
Polar Pharma India Limited is an India-based company. The Company is engaged in dealing with latex prophylactics.
- Market Cap ₹ Cr.
- Current Price ₹ 0.82
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -94.1
- Dividend Yield 0.00 %
- ROCE -20.5 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| 46 | 19 | 26 | 0 | 0 | 11 | 16 | |
| 74 | 23 | 26 | 11 | 2 | 9 | 18 | |
| Operating Profit | -28 | -5 | -0 | -11 | -2 | 2 | -2 |
| OPM % | -61% | -24% | -1% | -4,100% | -6,633% | 19% | -13% |
| 46 | -2 | 1 | -42 | 0 | 0 | 0 | |
| Interest | 3 | 5 | 5 | 4 | 12 | 13 | 15 |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 12 | -14 | -7 | -59 | -16 | -14 | -19 |
| Tax % | 44% | -33% | -64% | 15% | 0% | 0% | 0% |
| 6 | -9 | -3 | -68 | -16 | -14 | -19 | |
| EPS in Rs | 5.28 | -7.37 | -2.09 | -55.36 | -13.12 | -11.03 | -15.40 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | 296% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| TTM: | -40% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | -1 | -9 | -11 | -79 | -95 | -109 | -128 |
| 41 | 46 | 43 | 86 | 104 | 118 | 133 | |
| 16 | 12 | 9 | 13 | 8 | 9 | 6 | |
| Total Liabilities | 68 | 62 | 53 | 32 | 29 | 31 | 24 |
| 34 | 31 | 29 | 26 | 24 | 22 | 19 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 34 | 30 | 25 | 6 | 5 | 9 | 4 | |
| Total Assets | 68 | 62 | 53 | 32 | 29 | 31 | 24 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| 20 | -6 | 6 | -40 | 2 | -1 | 1 | |
| -1 | 1 | 1 | 0 | 0 | -0 | 0 | |
| -18 | 4 | -6 | 39 | -2 | 1 | 0 | |
| Net Cash Flow | 2 | -2 | 1 | -1 | -0 | 0 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 100 | 190 | 90 | 42 | 365 | 59 | 4 |
| Inventory Days | 228 | 458 | 83 | 110 | 4,198 | 365 | 64 |
| Days Payable | 96 | 53 | 20 | 136 | 20,622 | 346 | 68 |
| Cash Conversion Cycle | 232 | 596 | 153 | 16 | -16,060 | 77 | 0 |
| Working Capital Days | 127 | 264 | 67 | -10,697 | -37,230 | -35 | -69 |
| ROCE % | -11% | -4% | -35% | -21% | -1% | -20% |
Documents
Announcements
No data available.